Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001140361-19-020338
Filing Date
2019-11-12
Accepted
2019-11-12 16:22:54
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 nt10005799x1_424b5.htm 424B5 749704
2 logo_biocryst2.jpg GRAPHIC 63201
  Complete submission text file 0001140361-19-020338.txt   837806
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-221421 | Film No.: 191209839
SIC: 2836 Biological Products, (No Diagnostic Substances)